prazosin has been researched along with Arteriosclerosis, Coronary in 2 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piatak, OA | 1 |
| Yanovskii, GV | 1 |
| Lizogub, VG | 1 |
| Morozova, TE | 1 |
1 trial available for prazosin and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
Topics: Adult; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Exercise Tes | 1991 |
1 other study available for prazosin and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
[Use of prazosin in the treatment of heart failure in patients with post-infarction cardiosclerosis].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Coronary Artery Disease; Female; Hemodynamics; Humans; Male; M | 1990 |